Ignite Creation Date:
2024-05-06 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03379428
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-12
First Post:
2017-12-12
Brief Title:
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-12
First Submit QC Date:
December 14 2017
Study First Post Date:
2017-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-11
Last Update Post Date:
2024-01-12
Last Update Post Date Type:
ACTUAL